News Article | November 4, 2016
(October 18, 2016) – South-Florida-based Community Care Plan (formerly South Florida Community Care Network), the health plan with a heart, is pleased to announce that it has partnered with HealthCrowd, a healthcare communications technology, in an effort to encourage its enrollees to receive recommended preventative health services and close gaps in their care to promote wellness. The HealthCrowd platform unifies, automates and optimizes multimodal communications to deliver personalized member engagement. “At Community Care Plan, we are always looking to increase quality and provide our members with the most state-of-the-art tools and technologies, such as HealthCrowd, that can have a great impact on their health and well-being,” said John Benz, President and CEO of Community Care Plan. “HealthCrowd is a remarkable technology that will better help us to fill the gaps and encourage our members to seek out the healthcare that they need.” Community Care Plan currently has a number of HealthCrowd campaigns in place, targeting its pediatric population by encouraging child and adolescent well visits, immunizations and dental care. Community Care Plan enrollees are enrolled in HealthCrowd campaigns based on their gaps in care. Enrollees or their parents/guardians receive text messages that explain the program and then advise them as to what services they are missing. HealthCrowd is an interactive service, so recipients have the ability to respond back with keywords that can provide them with further assistance, such as finding a dentist near them or obtaining transportation. For enrollees who want to learn more about a particular topic, such as a specific immunization, they may be directed to “nano-sites” which are links to web based information that they can read and use to discuss with their provider. HealthCrowd also provides Community Care Plan with weekly reports to evaluate the success of the outreach and impact of this program. At any time, enrollees have the ability to opt out of the service as well as report they have obtained the recommended care. Introduced in 2000, originally as South Florida Community Care Network, as the first safety-net, hospital-owned Provider Service Network (PSN), Community Care Plan, serves members enrolled in Medicaid, Children’s Medical Services Network and self-insured employee health plans. Headquartered in Sunrise, Florida, Community Care Plan is a partnership owned by Broward Health and Memorial Healthcare System and is led by healthcare industry veteran John A. Benz, President & CEO of the company. Community Care Plan’s mission is to positively impact the health and welfare of those that the company serves. The organization’s health plans cover a wide range of health and medical services and offer an excellent choice of physicians and other benefits that help enrollees get and stay healthy. The non-profit organization is fully accredited by the Accreditation Association for Ambulatory Health Care (AAAHC) as a Health Plan and is currently the only remaining Provider Service Network in the state of Florida. About Community Care Plan (Community Care Plan is a MCP with a Florida Medicaid Contract) Launched in 2000 as the first safety-net hospital-owned Provider Service Network as South Florida Community Care Network, LLC (SFCCN), Community Care Plan is a Broward County health plan serving members enrolled in Medicaid, Children’s Medicaid Services Network and self-insured employee health plans. Community Care Plan is a partnership fully owned and operated by Broward Health (North Broward Hospital District) and Memorial Healthcare System (South Broward Hospital District). The organization strives to promote healthy living by providing local access to a high standard of healthcare and educational resources throughout the community. By improving the quality of care for Medicaid recipients, Community Care Plan seeks to earn patient and customer satisfaction, enhance professional fulfillment and provide public service. Community Care Plan is accredited by the Accreditation Association for Ambulatory Health Care (AAAHC) as a Health Plan. For more information, please visit http://www.CCPcares.org. About HealthCrowd HealthCrowd is a truly unified, end-to-end communications platform for healthcare. This technology unifies, automates and optimizes multimodal communications to deliver personalized member engagement. By fusing healthcare domain expertise with ad analytics, HealthCrowd has pioneered dynamic content, language-appropriate translations for mobile messaging, and popularized the application of online advertising techniques like multivariate testing in member engagement. For more information, please visit http://www.healthcrowd.com. Disclaimers: (1) “The benefit information provided is a brief summary, not a complete description of benefits. For more information, contact the Managed Care Plan.” (2) “Limitations, copayments, and restrictions may apply.” (3) “[Benefits, formulary, pharmacy network, premium and/or co-payments/co- insurance] may change.” (4) Community Care Plan is a Managed Care Plan with a Florida Medicaid Contract.
Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: Analysis of the etravirine early access program in the United States
Towner W.,Kaiser Permanente |
Lalezari J.,Quest Clinical Research |
Sension M.G.,North Broward Hospital District |
Wohlfeiler M.,Piperato and Associates LLC |
And 9 more authors.
Journal of Acquired Immune Deficiency Syndromes | Year: 2010
Background: Etravirine, a nonnucleoside reverse transcriptase inhibitor, was provided through an international early access program (EAP) prior to regulatory approval. Methods: The Phase III, nonrandomized, open-label EAP investigated etravirine 200 mg twice daily plus a background regimen (BR) in patients who had failed multiple antiretroviral regimens. Efficacy and safety are reported for HIV-infected adults from the United States through week 48, including subgroups receiving etravirine ± darunavir/ritonavir and/or raltegravir. Results: The intent-to-treat population included 2578 patients; 62.4% and 56.7% of patients received darunavir/ritonavir and raltegravir, respectively, in their BR. At week 48, 62.3% of patients achieved viral loads <75 copies per milliliter; responses across subgroups were similar. Median CD4+ count increase from baseline was >100 cells per cubic millimeter. No unexpected safety concerns emerged; serious AEs and deaths due to AEs, considered possibly related to etravirine, occurred in 2.0% and 0.3% of patients, respectively. Discontinuations due to AEs were low overall (4.4%) and comparable across subgroups. Conclusions: Etravirine combined with a BR, often including other new antiretrovirals, such as darunavir/ritonavir and/or raltegravir, provided an effective treatment option in treatment-experienced patients with HIV-1. © 2010 by Lippincott Williams & Wilkins.
North Broward Hospital District | Date: 2011-09-20
Printed matter, namely, newspapers, photographs, books, magazines, printed periodicals, newsletters and brochures featuring general interest, medicine, disease management, wellness, preventative medicine, and medical procedures.